- Home
- SXI vs BCRX Comparison
SXI vs BCRX Comparison
Compare SXI & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXI
- BCRX
- Stock Information
- Founded
- SXI 1955
- BCRX 1986
- Country
- SXI United States
- BCRX United States
- Employees
- SXI N/A
- BCRX N/A
- Industry
- SXI Industrial Machinery/Components
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SXI Industrials
- BCRX Health Care
- Exchange
- SXI Nasdaq
- BCRX Nasdaq
- Market Cap
- SXI 2.3B
- BCRX 1.9B
- IPO Year
- SXI N/A
- BCRX 1994
- Fundamental
- Price
- SXI $190.26
- BCRX $9.21
- Analyst Decision
- SXI Strong Buy
- BCRX Buy
- Analyst Count
- SXI 3
- BCRX 6
- Target Price
- SXI $231.33
- BCRX $15.50
- AVG Volume (30 Days)
- SXI 61.2K
- BCRX 3.1M
- Earning Date
- SXI 01-30-2025
- BCRX 02-24-2025
- Dividend Yield
- SXI 0.67%
- BCRX N/A
- EPS Growth
- SXI N/A
- BCRX N/A
- EPS
- SXI 4.56
- BCRX N/A
- Revenue
- SXI $717,739,000.00
- BCRX $412,579,000.00
- Revenue This Year
- SXI $9.81
- BCRX $38.44
- Revenue Next Year
- SXI $13.28
- BCRX $21.23
- P/E Ratio
- SXI $41.46
- BCRX N/A
- Revenue Growth
- SXI N/A
- BCRX 29.92
- 52 Week Low
- SXI $154.45
- BCRX $4.03
- 52 Week High
- SXI $212.66
- BCRX $9.50
- Technical
- Relative Strength Index (RSI)
- SXI 44.27
- BCRX 65.48
- Support Level
- SXI $185.45
- BCRX $8.63
- Resistance Level
- SXI $192.41
- BCRX $9.00
- Average True Range (ATR)
- SXI 4.73
- BCRX 0.36
- MACD
- SXI -0.41
- BCRX 0.07
- Stochastic Oscillator
- SXI 39.00
- BCRX 85.20
About SXI Standex International Corporation
Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. It has five reportable segments; Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. The maximum revenue is generated from its Electronics segment which is a component and value-added services provider of both sensing and switching technologies as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging among others. Geographically, it derives key revenue from the United States and the rest from Asia Pacific, Europe, Middle East and South Africa (EMEA), and other regions.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.